- Home
- JAZZ vs SIGI Comparison
JAZZ vs SIGI Comparison
Compare JAZZ & SIGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- SIGI
- Stock Information
- Founded
- JAZZ 2003
- SIGI 1926
- Country
- JAZZ Ireland
- SIGI United States
- Employees
- JAZZ 2800
- SIGI N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- SIGI Property-Casualty Insurers
- Sector
- JAZZ Health Care
- SIGI Finance
- Exchange
- JAZZ Nasdaq
- SIGI Nasdaq
- Market Cap
- JAZZ 7.0B
- SIGI 5.5B
- IPO Year
- JAZZ 2007
- SIGI N/A
- Fundamental
- Price
- JAZZ $108.05
- SIGI $78.36
- Analyst Decision
- JAZZ Strong Buy
- SIGI Hold
- Analyst Count
- JAZZ 12
- SIGI 7
- Target Price
- JAZZ $183.00
- SIGI $87.33
- AVG Volume (30 Days)
- JAZZ 628.2K
- SIGI 756.4K
- Earning Date
- JAZZ 08-05-2025
- SIGI 07-23-2025
- Dividend Yield
- JAZZ N/A
- SIGI 1.95%
- EPS Growth
- JAZZ 49.21
- SIGI 66.75
- EPS
- JAZZ 7.51
- SIGI 6.11
- Revenue
- JAZZ $4,064,808,000.00
- SIGI $5,112,631,000.00
- Revenue This Year
- JAZZ $6.10
- SIGI $5.31
- Revenue Next Year
- JAZZ $5.07
- SIGI $6.91
- P/E Ratio
- JAZZ $15.07
- SIGI $12.78
- Revenue Growth
- JAZZ 5.76
- SIGI 12.30
- 52 Week Low
- JAZZ $95.49
- SIGI $71.75
- 52 Week High
- JAZZ $148.06
- SIGI $103.56
- Technical
- Relative Strength Index (RSI)
- JAZZ 37.52
- SIGI 39.20
- Support Level
- JAZZ $112.17
- SIGI $76.37
- Resistance Level
- JAZZ $117.39
- SIGI $81.37
- Average True Range (ATR)
- JAZZ 2.64
- SIGI 3.32
- MACD
- JAZZ -0.80
- SIGI -0.69
- Stochastic Oscillator
- JAZZ 4.61
- SIGI 31.49
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About SIGI Selective Insurance Group Inc.
Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. The Company has four operating segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, Investments. Majority of revenue is gained from Standard Personal Lines. Currently company has it's revenues from States of USA and Columbia.